The tumor necrosis factor (TNF) inhibitors have been successfully used in the treatment of sarcoidosis, with improvement noted in recalcitrant cutaneous lesions.1,2
We report 5 cases of cutaneous sarcoidosis treated with TNF inhibitors, including 2 patients who had an excellent response to adalimumab and 3 patients demonstrating significant improvement in their cutaneous lesions after treatment with infliximab. The Table provides a summary of the clinical characteristics and prior treatments of these patients.
Wanat KA, Rosenbach M. Case Series Demonstrating Improvement in Chronic Cutaneous Sarcoidosis Following Treatment With TNF Inhibitors. Arch Dermatol. 2012;148(9):1097–1100. doi:10.1001/archdermatol.2012.1322
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: